pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 13·1 min read
save

FDA commissioner resigns as Marty Makary steps down, Bill Cassidy faces tough primary

May 13, 2026·read at STAT ↗RegulatoryNeutral

The newsletter highlights that extreme heat is worsening faster for Black Americans, underscoring a growing health disparity.

FDA Commissioner Marty Makary resigned yesterday, and Kyle Diamantas, the agency's top food regulator, will assume the role of acting commissioner.

Commentators described Makary as the worst FDA commissioner in the past 25 years.

Louisiana physician‑senator Bill Cassidy is confronting a difficult primary contest, with former President Trump endorsing one of his challengers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Extreme heat is worsening faster for Black Americans”

read at STAT ↗
1,203 words · retrieved May 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGRISING
drugs
MIFEPRISTONE
topics
Psychiatry & CNS3Endocrinology & Metabolism2Hepatology2Gene Therapy (AAV)Oncology

related stories

  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 4h agoEyepoint, Enlivex enact heavy layoffsBioSpace
  • Oct 75 biggest venture capital raises of Q3 2026BioSpace
  • Oct 5Swiss CDMOs and CROs ride a new wave of growth amid surge in global demandBioSpace